A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
Clinical trial NCT05926583 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05926583
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2027-06-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.